Role of Individual Clinician Authority in the Implementation of Informatics Tools for Population-Based Medication Management: Qualitative Semistructured Interview Study.

DOAC EHR EHRs anticoagulant anticoagulants clot clots clotting dashboard direct oral anticoagulant electronic health record health records implementation implementation science individual clinician authority interview interviews medical informatics medication pharmacist pharmacology pharmacy population management prescribe prescribing satisfaction

Journal

JMIR human factors
ISSN: 2292-9495
Titre abrégé: JMIR Hum Factors
Pays: Canada
ID NLM: 101666561

Informations de publication

Date de publication:
24 10 2023
Historique:
received: 19 05 2023
accepted: 02 09 2023
revised: 16 08 2023
medline: 25 10 2023
pubmed: 24 10 2023
entrez: 24 10 2023
Statut: epublish

Résumé

Direct oral anticoagulant (DOAC) medications are frequently associated with inappropriate prescribing and adverse events. To improve the safe use of DOACs, health systems are implementing population health tools within their electronic health record (EHR). While EHR informatics tools can help increase awareness of inappropriate prescribing of medications, a lack of empowerment (or insufficient empowerment) of nonphysicians to implement change is a key barrier. This study examined how the individual authority of clinical pharmacists and anticoagulation nurses is impacted by and changes the implementation success of an EHR DOAC Dashboard for safe DOAC medication prescribing. We conducted semistructured interviews with pharmacists and nurses following the implementation of the EHR DOAC Dashboard at 3 clinical sites. Interview transcripts were coded according to the key determinants of implementation success. The intersections between individual clinician authority and other determinants were examined to identify themes. A high level of individual clinician authority was associated with high levels of key facilitators for effective use of the DOAC Dashboard (communication, staffing and work schedule, job satisfaction, and EHR integration). Conversely, a lack of individual authority was often associated with key barriers to effective DOAC Dashboard use. Positive individual authority was sometimes present with a negative example of another determinant, but no evidence was found of individual authority co-occurring with a positive instance of another determinant. Increased individual clinician authority is a necessary antecedent to the effective implementation of an EHR DOAC Population Management Dashboard and positively affects other aspects of implementation. RR2-10.1186/s13012-020-01044-5.

Sections du résumé

BACKGROUND
Direct oral anticoagulant (DOAC) medications are frequently associated with inappropriate prescribing and adverse events. To improve the safe use of DOACs, health systems are implementing population health tools within their electronic health record (EHR). While EHR informatics tools can help increase awareness of inappropriate prescribing of medications, a lack of empowerment (or insufficient empowerment) of nonphysicians to implement change is a key barrier.
OBJECTIVE
This study examined how the individual authority of clinical pharmacists and anticoagulation nurses is impacted by and changes the implementation success of an EHR DOAC Dashboard for safe DOAC medication prescribing.
METHODS
We conducted semistructured interviews with pharmacists and nurses following the implementation of the EHR DOAC Dashboard at 3 clinical sites. Interview transcripts were coded according to the key determinants of implementation success. The intersections between individual clinician authority and other determinants were examined to identify themes.
RESULTS
A high level of individual clinician authority was associated with high levels of key facilitators for effective use of the DOAC Dashboard (communication, staffing and work schedule, job satisfaction, and EHR integration). Conversely, a lack of individual authority was often associated with key barriers to effective DOAC Dashboard use. Positive individual authority was sometimes present with a negative example of another determinant, but no evidence was found of individual authority co-occurring with a positive instance of another determinant.
CONCLUSIONS
Increased individual clinician authority is a necessary antecedent to the effective implementation of an EHR DOAC Population Management Dashboard and positively affects other aspects of implementation.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
RR2-10.1186/s13012-020-01044-5.

Identifiants

pubmed: 37874636
pii: v10i1e49025
doi: 10.2196/49025
pmc: PMC10630856
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e49025

Subventions

Organisme : AHRQ HHS
ID : R18 HS026874
Pays : United States

Informations de copyright

©Allison Ranusch, Ying-Jen Lin, Michael P Dorsch, Arthur L Allen, Patrick Spoutz, F Jacob Seagull, Jeremy B Sussman, Geoffrey D Barnes. Originally published in JMIR Human Factors (https://humanfactors.jmir.org), 24.10.2023.

Références

J Gen Intern Med. 2020 Jan;35(1):371-373
pubmed: 31664597
J Am Med Inform Assoc. 2017 Jan;24(1):193-197
pubmed: 27107439
Nurs Adm Q. 1996 Spring;20(3):42-9
pubmed: 8710222
J Am Heart Assoc. 2021 Dec 21;10(24):e022758
pubmed: 34796718
Int J Nurs Stud. 2012 Aug;49(8):1017-38
pubmed: 22189097
BMC Health Serv Res. 2010 Aug 06;10:231
pubmed: 20691097
J Multidiscip Healthc. 2017 Jun 10;10:227-234
pubmed: 28652761
Circ Cardiovasc Qual Outcomes. 2023 Feb;16(2):e009256
pubmed: 36484253
Implement Sci. 2023 Jul 26;18(1):32
pubmed: 37495997
Circ Cardiovasc Qual Outcomes. 2021 Dec;14(12):e007971
pubmed: 34932377
Med Care. 2021 Jul 1;59(7):625-631
pubmed: 33797506
J Thromb Thrombolysis. 2021 Jul;52(1):200-208
pubmed: 33222115
Br J Oral Maxillofac Surg. 2017 Jun;55(5):449-453
pubmed: 28343734
Res Pract Thromb Haemost. 2022 Feb 07;6(1):e12662
pubmed: 35155978
Am J Health Syst Pharm. 2011 Jan 15;68(2):115
pubmed: 21200055
Med Educ Online. 2011 Apr 08;16:
pubmed: 21519399
Res Social Adm Pharm. 2011 Sep;7(3):306-16
pubmed: 21454135
Implement Sci Commun. 2023 Mar 13;4(1):25
pubmed: 36915186
Acad Emerg Med. 2004 Dec;11(12):1341-5
pubmed: 15576526
Healthc (Amst). 2018 Mar;6(1):7-12
pubmed: 28716376
Best Pract Res Clin Anaesthesiol. 2011 Jun;25(2):133-44
pubmed: 21550539
Clin Infect Dis. 2010 Nov 1;51(9):1074-80
pubmed: 20879856
Implement Sci Commun. 2022 Feb 2;3(1):10
pubmed: 35109916
BMJ. 2022 May 25;377:e059818
pubmed: 35613721
Milbank Q. 2013 Sep;91(3):459-90
pubmed: 24028696

Auteurs

Allison Ranusch (A)

Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, United States.

Ying-Jen Lin (YJ)

Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI, United States.

Michael P Dorsch (MP)

College of Pharmacy, University of Michigan, Ann Arbor, MI, United States.
Institute for Health Policy and Innovation, University of Michigan, Ann Arbor, MI, United States.

Arthur L Allen (AL)

Veterans Affairs, Salt Lake City Health Care System, Salt Lake City, UT, United States.

Patrick Spoutz (P)

Veterans Integrated Service Network 20 Northwest Network, Vancouver, WA, United States.

F Jacob Seagull (FJ)

Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI, United States.

Jeremy B Sussman (JB)

Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, United States.
Institute for Health Policy and Innovation, University of Michigan, Ann Arbor, MI, United States.
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.

Geoffrey D Barnes (GD)

Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI, United States.
Institute for Health Policy and Innovation, University of Michigan, Ann Arbor, MI, United States.
Division of Cardiovascular Medicine, Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH